An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease

This study has been completed.
Information provided by:
Tillotts Pharma AG Identifier:
First received: December 15, 2003
Last updated: February 20, 2007
Last verified: October 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2005
  Estimated Primary Completion Date: No date given
No publications provided by Tillotts Pharma AG

Publications automatically indexed to this study by Identifier (NCT Number):